Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
escherichia coli nissle 1917 (1 trial)
curcumin (4 trials)
6-prenylnaringenin (2 trials)
8-prenyl-naringenin (1 trial)
oryza sativa (1 trial)
resveratrol (1 trial)
bifidobacterium lactis (1 trial)
caffeine (1 trial)
eicosapentanoic acid (1 trial)
genistein (1 trial)
Lactobacillus acidophilus (1 trial)
lactobacillus casei (1 trial)
maltodextrin (1 trial)
omega-3 fatty acids (Omacor) (2 trials)
orange juice (1 trial)
phaeodactylum (1 trial)
quercetin (1 trial)
resistant starch (1 trial)
taurine (1 trial)
turmeric (1 trial)
vitamin d3 (1 trial)
xanthohumol (1 trial)
Colorectal Neoplasms (Phase 3)
Metabolic Syndrome (Phase 2)
Stomach Neoplasms (Phase 3)
Syndrome (Phase 2)
Trials (18 total)
Trial APIs (22 total)